Psychedelics – News and Features

Bryan Roth's lab at UNC-Chapel Hill have solved the structure of the LSD-bound serotonin receptor. The work took several years to produce but could open up therapeutic approaches in the treatment of stress and headaches.

When combined with psychological counseling, a single dose of a mind-altering compound contained in psychedelic mushrooms significantly lessens mental anguish in distressed cancer patients for months at a time, according to results of a clinical trial led by researchers at NYU Langone Medical Center.

Study extends popular 'balanced network theory'.

NCI accepts recommendations for approaches likely to make progress against cancer under the Cancer Moonshot

The consumption of LSD, short for lysergic acid diethylamide, can produce altered states of consciousness. This can lead to a loss of boundaries between the self and the environment, as might occur in certain psychiatric illnesses.

Improved accuracy could allow researchers to measure brain temperature in times of trauma when small deviations in temperature can lead to additional brain injury.

MDMA, more commonly known as ecstasy, promotes strong feelings of empathy in users and is classified as a Schedule 1 drug in the [US]—a category reserved for compounds with no accepted medical use and a high abuse potential.

An experimental drug prevented learning deficits in young mice exposed repeatedly to anesthesia, according to a study led by researchers from NYU Langone Medical Center and published in Science Translational Medicine.

New insight from depressed mice helps researchers unite two hypotheses.

NIH-funded team finds rapid-acting, non-addicting agent in mouse study.